IRADIMED Corp (IRMD): Market Cap to Revenue

Symbol and logo of brand IRADIMED Corp (IRMD)

IRADIMED CORPORATION (IRMD) is implementing eco-friendly production standards and ESG principles to reduce energy costs. The company strives for dominance in the MRI-compatible equipment segment by creating unique infusion systems. Sustained demand across global medical centers solidifies its monopoly position. The value of 12.20 shows the current volume of the metric, which is clearly illustrated in the price-to-sales ratio.

IRMD IRADIMED Corp P/S Multiple (07/04/2022 - 11/13/2026)

Analytical breakdowns for Iradimed (IRMD)

- share price and consensus valuation forecast:
Price Performance Chart iradimed.com|IRMD - Price Target Chart
- stock exchange capitalization data:
Market Valuation Iradimed|IRMD - Enterprise Value
- book value of equity indicators:
Net Asset Value per Share IRADIMED|IRMD - Book Capitalization|Capitalization to Book Value Ratio iradimed.com|IRMD - Company Total Assets
- debt obligations and liquidity statistics:
Total Debt to Capital Coefficient IRADIMED CORPORATION|IRMD - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio IRADIMED Inc.|IRMD - Company Aggregate Debts|Debts to Book Capitalization Iradimed|IRMD - Company Long-Term Debt|Company Short-Term Debt IRADIMED|Intermediate Coverage Ratio iradimed.com
- earnings and multiples data:
IRMD - Net Profit|Expected Net Profit IRADIMED CORPORATION|IRMD - Price to Earnings Ratio|Forward Price to Earnings Multiple IRADIMED Corp|IRMD - Price/Earnings to Growth Multiple|EV/EBITDA Multiple Iradimed|IRMD - Operating profit EBITDA|Net earnings per share for the last four quarters IRADIMED|IRMD - Earnings per share for the last twelve months|Year-over-year net earnings per share trend for the last twelve months iradimed.com|IRMD - Earnings per share growth in current year|Expected earnings per share growth for next year IRADIMED CORPORATION
- issuer revenue and sales details:
IRMD - Revenue and Sales Volume|Company Expected Sales Volume iradimed.com|IRMD - Price-to-Revenue Ratio|Market Cap to Projected Revenue Iradimed
General company analysis:IRMD iradimed.com
Core merchandise of IRADIMED CORPORATION

The scale of MRI equipment production at IRADIMED CORPORATION (IRMD) and the implementation of energy-efficient ESG technologies are reflected in the revenue multiple dynamics. This indicator compares market capitalization with annual sales volume, determining the cost of each dollar of revenue and allowing investors to assess whether the business is overvalued or undervalued relative to its ability to generate cash flow.

Competitors of IRADIMED CORPORATION

BSX (bostonscientific.com) - Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio Edwards Lifesciences Corporation EW|RMD - Market Cap to Revenue|OmniPod - P/S Multiple|Price to Sales Zimmer Biomet Holdings|COO: P/S Multiple|Market Cap to Revenue Ratio ALGN|GMED (Globus Medical) - P/S Multiple|TransMedics Group Inc (TMDX) - Price-to-Revenue Coefficient|P/S Multiple ATEC|Market Cap to Revenue Artivion Corp AORT|P/S Multiple ENOV (Enovis Corporation)|P/S Multiple integralife.com IART|ESTA - Price-to-Revenue Ratio|BBNX: Price-to-Revenue Ratio|EMBC (Embecta Inc.) - Market Cap to Revenue|Tandem Corp - Market Capitalization-to-Revenue Ratio|AXGN (AxoGen, Inc.) - P/S Multiple|Price to Sales si-bone.com SIBN|Price-to-Revenue Ratio Orthofix (OFIX)|Bioventus Inc (BVS) - Price-to-Revenue Multiple|OrthoPediatrics - Market Cap to Revenue|P/S Multiple Treace Corp TMCI|Strata Critical Medical Inc - P/S Multiple|Price-to-Revenue Coefficient carlsmed.com CARL|RxSight (RXST) - Price-to-Revenue Ratio|Price-to-Sales Ratio CLPT (ClearPoint Neuro)|Price-to-Revenue Ratio Stereotaxis Corp|Market Cap to Revenue Neuronetics, Inc (STIM)|P/S Multiple SGHT|OBIO - Price to Sales|Price-to-Revenue Ratio Anika Therapeutics, Inc. ANIK|NSPR: Market Cap to Revenue Ratio|ZJYL: Market Cap to Revenue|Vivani Medical, Inc. - Market Cap to Sales Volume|XTNT: P/S Multiple|NMTC - Price-to-Revenue Coefficient|Price-to-Revenue Ratio Modular Medical Inc|MYO: Market Capitalization-to-Revenue Ratio|P/S Multiple COCH|P/S Multiple Vivos Therapeutics Inc (VVOS)|P/S Multiple NVNO (enVVeno Medical)|SINT: Market Cap to Revenue Ratio|Tenon Medical - P/S Multiple|Price-to-Revenue Coefficient ReWalk Robotics LFWD|autonomix.com (AMIX) - Price-to-Revenue Ratio|Market Cap to Revenue INVO Fertility Corp|BBLG (Bone Biologics) - P/S Multiple|Price to Sales axonics.com AXNX|P/S Multiple BIOL|dynatronics.com - Market Cap to Revenue Ratio|Paragon 28 - Market Cap to Revenue|Market Capitalization-to-Revenue Ratio INVO